Drug Shortage Report for MINT-CITALOPRAM
Report ID | 121279 |
Drug Identification Number | 02429713 |
Brand name | MINT-CITALOPRAM |
Common or Proper name | Citalopram |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 count Blisters |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-07-28 |
Actual start date | |
Estimated end date | 2021-02-28 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-12-07 |
Company comments | |
Health Canada comments | |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.